Clinical Trial Data on VR Intervention for Cancer-Related Fear in 63 Patients

63 gynecological cancer patients were randomly allocated to a VR intervention or control group in a clinical trial. The dataset, authored by Bo Wang and last updated in April 2026, contains outcome measures for fear of cancer recurrence, illness uncertainty, and hope collected at baseline and three follow-up points over three months.

Use Cases

• Analyzing the mediating effects of illness uncertainty and hope on fear of cancer recurrence based on the described mediation analysis.
• Evaluating the temporal dynamics of a psychological intervention's effect based on measurements at 1 week, 1 month, and 3 months post-intervention.
• Studying the efficacy of chronotype-aligned therapy scheduling based on the use of the Morningness-Eveningness Questionnaire.
• Comparing intervention and control group outcomes for fear of cancer recurrence scores based on the reported mean differences and effect sizes.

Strengths

• Data from a randomized controlled trial with 63 participants and well-balanced baseline characteristics.
• Outcomes measured at four time points, allowing for analysis of temporal dynamics over a 3-month period.
• Reported large effect sizes (partial η² = 0.535–0.617) for the primary outcome.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The 1.0 MB file size suggests a small dataset, potentially limiting statistical power for complex analyses.

Provenance

Source

figshare, author Bo Wang.

Collection Method

Data collected from a randomized controlled trial involving a 4-week VR intervention.

Time Range

Data collection covered baseline and follow-ups at 1 week, 1 month, and 3 months post-intervention.

Freshness

Last updated 2026-04-13 05:20:42; freshness should be verified.

Geography

null